Trial Profile
Efficacy of telmisartan versus enalapril in hypertensive patients with metabolic disturbances and renal dysfunction
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 May 2012
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary) ; Enalapril
- Indications Hypertension
- Focus Therapeutic Use
- 29 Apr 2012 Results presented at the 22nd European Meeting on Hypertension.
- 05 Nov 2010 New trial record.